The Institute of Gastroenterology and Hepatology signed a joint research agreement with Tokyo-based medtech start-up AI Medical Service, which is focused on the development of diagnostic endoscopic artificial intelligence.
Collaborative research activities will begin Oct. 27, according to an Oct. 11 news release. AI Medical is the first Japanese company to sign a joint research agreement with IGH in the field of endoscopy and AI.
AI Medical is working toward regulatory approval in Japan for its endoscopic AI device designed to identify early-stage gastrointestinal cancers. The collaboration will facilitate joint research to test the endoscopic AI device in Vietnam, the release said.